TechConnect #techconnect keeps getting better every year! Anaheim was a great location, with a good mix of entrepreneurs and investors! Looking forward to the next one in Boston in May 2019. I chaired a very engaging panel of experts who elaborated on the biggest problem facing the industrial production of uniform nanoparticles. I showcased Notre Dame’s expanding Nanoparticles synthesis capabilities. Prof. Leevy talked about the challenges of being an entrepreneur in an academic setting and how Notre Dame’s IDEA center #IDEAcenter is making that process easier. Dr. Andrew Wang, the co-founder of Ocean Nanotech and Alpha BioBeads, talked about the current challenges of commercially synthesizing nanomaterials. Dr. Wei Wang or Saudi Aramco Research Center further expounded on the need to translate nanotechnology from a working concept in the lab to a fully working field instrument in challenging environments such as offshore oil wells. Finally, Dr. Parlak who founded ‘Qatch diagnostics technologies’ talked about the joys, pains and unique satisfaction of running a startup.
May 14
TechConnect 2018 an SBIR/STTR Haven
Categories:
Berthiaume Institute for Precision Health, Biomedical Imaging, Conference abstracts, SBIR/STTR
by Prakash
This post has no tag
Recent Posts
- Phage-Mimicking Antibacterial Nanoparticles Tackle Group A Streptococcal Infections In Vivo January 29, 2024
- 2nd Annual Berthiaume Institute for Precision Health’s Advisory Board Meeting October 30, 2023
- 1st Place Poster at the Military Health Sciences Research Symposium 2023 (Aug 14-17, Kissimmee, FL) August 14, 2023
- Congratulations to Ms. Johanna Olesk on Defending her MS (Bioengineering) ’23 Thesis July 7, 2023
- Translational Science to Impact Public Health was our Goal at Techconnect 2023 June 17, 2023
Archives
Categories
NIH Funding Opportunities
- NINDS Policy for applications requesting $500,000 or more in direct costs in any year (excluding consortium F and A)on NIH Parent R01 Notices of Funding Opportunities April 26, 2024Notice NOT-NS-24-079 from the NIH Guide for Grants and Contracts
- NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional) April 26, 2024Funding Opportunity RFA-HL-26-002 from the NIH Guide for Grants and Contracts. The purpose of the NHLBI Outstanding Investigator Award (OIA) is to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program Directors/Principal Investigators (PDs/PIs) who are currently PDs/PIs on at least two NHLBI R01-equivalent awards and whose outstanding record […]
- NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional) April 26, 2024Funding Opportunity RFA-HL-26-003 from the NIH Guide for Grants and Contracts. The purpose of the NHLBI Emerging Investigator Award (EIA) is to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program Directors/Principal Investigators (PDs/PIs) who are currently PDs/PIs on at least two NHLBI R01-equivalent awards and whose outstanding record […]
- Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required) April 26, 2024Funding Opportunity RFA-DK-25-004 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to continue support for the TrialNet Coordinating Center (TNCC). The TrialNet network identifies people with type 1 diabetes (T1D) at stages before and after onset of clinical symptoms and enrolls them in trials and […]
- NIDCD Individual Fellowship Pre-Application Information Session April 26, 2024Notice NOT-DC-24-026 from the NIH Guide for Grants and Contracts
- Notice of Special Interest (NOSI): Administrative Supplement to Support the NCI Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Research April 26, 2024Notice NOT-CA-24-047 from the NIH Guide for Grants and Contracts
- Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required) April 26, 2024Funding Opportunity PAR-24-132 from the NIH Guide for Grants and Contracts. Through this Notice of Funding Opportunity (NOFO), the National Institutes of Health (NIH) aims to facilitate the career development and transition of investigators new to entrepreneurship with an interest in small business by simultaneously supporting their entrepreneurial development and the conduct of research and […]
- Independent Scientist Award (Parent K02 Independent Basic Experimental Studies with Humans Required) April 26, 2024Funding Opportunity PA-24-180 from the NIH Guide for Grants and Contracts. The purpose of the NIH Independent Scientist Award (K02) is to foster the development of outstanding scientists and enable them to expand their potential to make significant contributions to their field of research. The K02 award provides three to five years of salary support […]
- Independent Scientist Award (Parent K02 - Independent Clinical Trial Required) April 26, 2024Funding Opportunity PA-24-178 from the NIH Guide for Grants and Contracts. The purpose of the NIH Independent Scientist Award (K02) is to foster the development of outstanding scientists and enable them to expand their potential to make significant contributions to their field of research. The K02 award provides three to five years of salary support […]
- Notice of Budget Change in RFA-AI-24-006 Centers for Research in Emerging Infectious Diseases (CREID) Network (U01 Clinical Trial Not Allowed) April 25, 2024Notice NOT-AI-24-046 from the NIH Guide for Grants and Contracts
Recent Comments